Skip to main content

Search

Show all results for

Home

Person

Marc Chambon

About
Privacy
Disclaimer

Copyright © 2026 EPFL, all rights reserved

Graph Chatbot

Official source

https://people.epfl.ch/marc.chambon

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Courses taught by this person (1)

BIOENG-518: Methods: from disease models to therapy

This course will describe methods underlying translational approaches from disease modeling and characterization to therapeutic applications. The presented techniques will be complemented by hands-on

Related publications (15)

Please note that this is not a complete list of this person’s publications. It includes only semantically relevant works. For a full list, please refer to Infoscience.

An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs

Gerardo Turcatti, Marc Chambon

Elimination of malaria will require new drugs with potent activity against Plasmodium falciparum mature stage V gametocytes, the only stages infective to the mosquito vector. The identification and comprehensive validation of molecules active against these ...

2025

Identification of glutathione transferase (GST P1) inhibitors via a high-throughput screening assay and implications as alternative treatment options for breast cancers

Gerardo Turcatti, Marc Chambon, Jonathan Patrice Vesin, Paul Joseph Dyson

Glutathione S-transferase P1-1 (GST P1) is an important drug target as it is implicated in drug resistance. GST P1-1 inhibitors are typically non-productive analogues of glutathione which covers broad chemical space; hence it is likely that several clinica ...

Public Library of Science (PLoS)2025

Repurposing drug screen of patient-derived malignant pleural mesothelioma cells reveals potential anti-cancer activity

Gerardo Turcatti, Marc Chambon

ELSEVIER SCIENCE INC2023